Vaccine development for syphilis
نویسندگان
چکیده
منابع مشابه
The search for a vaccine for syphilis. An epidemiological approach.
Attempts to devise a vaccine against syphilis have been pursued for decades but thus far with little success. For the most part investigations have been focused on Treponema pallidum, modified in various ways, on the Reiter treponeme and its protein fractions, and on the closely related Borrelia organism. Inoculation with Treponema pallidum produces a degree ofimmunity to re-infection and Neiss...
متن کاملViral Vectors for Vaccine Development
Recombinant vectors can be used to deliver antigens and to stimulate immune responses in humans. Viral vectors possess various intrinsic properties which may lend to advantages and disadvantages for usage for a given therapeutic application [reviewed by Larocca and Schlom] [1]. The safety and flexibility of recombinant viral vectors have lead to their usage in gene therapy, virotherapy, and vac...
متن کاملTargeting TLR2 for Vaccine Development
Novel and more effective immunization strategies against many animal diseases may profit from the current knowledge on the modulation of specific immunity through stimulation of innate immune receptors. Toll-like receptor (TLR)2-targeting formulations, such as synthetic lipopeptides and antigens expressed in fusion with lipoproteins, have been shown to have built-in adjuvant properties and to b...
متن کاملVaccine development for rheumatoid arthritis
Rheumatoid arthritis (RA) is an autoimmune disorder characterized by chronic synovial joint inflammation, destruction of articular cartilage and erosion of subchondral bone. Major advances have been made in the medical management of RA with the introduction of various types of biologic drugs which neutralize the activity of pro-inflammatory cytokines as well as T-cell and B-cell proliferation. ...
متن کاملStrategies for Cancer Vaccine Development
Treating cancer with vaccines has been a challenging field of investigation since the 1950s. Over the years, the lack of effective active immunotherapies has led to the development of numerous novel strategies. However, the use of therapeutic cancer vaccines may be on the verge of becoming an effective modality. Recent phase II/III clinical trials have achieved hopeful results in terms of overa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Review of Vaccines
سال: 2016
ISSN: 1476-0584,1744-8395
DOI: 10.1080/14760584.2016.1203262